Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL/6 Model
2007

Optimizing Treatment for Cutaneous Leishmaniasis with WR279396

Sample size: 60 publication 10 minutes Evidence: high

Author Information

Author(s): Lecoeur Hervé, Buffet Pierre, Morizot Gloria, Goyard Sophie, Guigon Ghislaine, Milon Geneviève, Lang Thierry

Primary Institution: Institut Pasteur, Paris, France

Hypothesis

Can the efficacy of topical therapy for localized cutaneous leishmaniasis be improved using an occlusive dressing?

Conclusion

Using an occlusive dressing significantly enhances the efficacy of WR279396 in treating localized cutaneous leishmaniasis in mice.

Supporting Evidence

  • 94% efficacy of WR279396 was observed with 10 daily applications in mice.
  • Occlusive dressing significantly increased treatment efficacy compared to no dressing.
  • Length of therapy was found to be more important than total dose applied.

Takeaway

This study found that a special ointment works better for treating skin infections when covered with a bandage, helping the medicine work faster and better.

Methodology

C57BL/6 mice were inoculated with L. major and treated with WR279396, with efficacy assessed through bioluminescence imaging and lesion size measurements.

Potential Biases

Potential bias in treatment allocation and assessment due to the lack of blinding.

Limitations

The study was conducted in a mouse model, which may not fully replicate human responses.

Participant Demographics

C57BL/6 mice, female, 5 weeks old.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000034

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication